Adult Dosing of Amoxicillin-Clavulanate for Community-Acquired Pneumonia
For otherwise healthy adults with community-acquired pneumonia and comorbidities (chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy; or asplenia), use amoxicillin-clavulanate 875 mg/125 mg twice daily OR 500 mg/125 mg three times daily OR the high-dose regimen of 2,000 mg/125 mg twice daily for respiratory tract infections. 1, 2
Dosing Algorithm Based on Patient Risk Category
For Healthy Adults WITHOUT Comorbidities
- First-line: Amoxicillin alone 1 g three times daily is preferred over amoxicillin-clavulanate 1
- Amoxicillin-clavulanate is NOT the recommended first choice in this population
For Adults WITH Comorbidities
The 2019 ATS/IDSA guidelines provide three FDA-approved dosing options as combination therapy 1:
Standard-dose regimens:
- 875 mg/125 mg twice daily (preferred for convenience and reduced GI side effects)
- 500 mg/125 mg three times daily
High-dose regimen:
- 2,000 mg/125 mg twice daily (extended-release formulation)
All three regimens must be combined with either a macrolide (azithromycin or clarithromycin) OR doxycycline 100 mg twice daily 1.
Key Dosing Considerations
High-Dose Formulation (2,000 mg/125 mg)
This pharmacokinetically enhanced extended-release formulation maintains amoxicillin concentrations above 4 mcg/mL for approximately 49% of the dosing interval, providing superior coverage against Streptococcus pneumoniae with reduced penicillin susceptibility (MICs up to 4 mg/L) 3, 4. Clinical trials demonstrate equivalent efficacy to standard dosing with 91.5-93% clinical success rates 3.
Administration
- Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 2
- The 875 mg/125 mg twice-daily regimen is associated with significantly less diarrhea compared to three-times-daily dosing 5
Critical Pitfalls to Avoid
Do NOT substitute formulations incorrectly:
- Two 250 mg/125 mg tablets ≠ one 500 mg/125 mg tablet (clavulanate content differs) 2
- The 250 mg/125 mg tablet and 250 mg/62.5 mg chewable tablet are NOT interchangeable 2
Do NOT use amoxicillin-clavulanate as monotherapy in adults with comorbidities—always add atypical coverage with a macrolide or doxycycline 1
Duration of Therapy
While the guidelines studied 10-day courses 1, emerging evidence supports shorter durations (3-7 days) based on clinical stability, though this represents evolving practice 6, 7.
Evidence Quality
The dosing recommendations carry a strong recommendation with moderate quality evidence for combination therapy in patients with comorbidities 1. Multiple RCTs confirm non-inferiority between dosing regimens, with the 875 mg twice-daily formulation offering practical advantages in adherence and tolerability 3, 5.